Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity
BPTSDelisted Stock | USD 7.03 0.00 0.00% |
Slightly above 56% of Biophytis' investor base is looking to short. The analysis of current outlook of investing in Biophytis suggests that many traders are alarmed regarding Biophytis' prospects. Biophytis' investing sentiment can be driven by a variety of factors including economic data, Biophytis' earnings reports, geopolitical events, and overall market trends.
Biophytis |
IND to be filed with the FDA in the coming weeksPARIS, FRANCE and CAMBRIDGE, MA ACCESSWIRE April 18, 2024 Biophytis SA , ,
Read at accesswire.com
Biophytis Fundamental Analysis
We analyze Biophytis' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biophytis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biophytis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Biophytis is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Biophytis Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biophytis stock to make a market-neutral strategy. Peer analysis of Biophytis could also be used in its relative valuation, which is a method of valuing Biophytis by comparing valuation metrics with similar companies.
Peers
Biophytis Related Equities
AKTX | Akari Therapeutics | 1.00 | ||||
CHRS | Coherus BioSciences | 0.62 | ||||
INBX | Inhibrx | 0.27 | ||||
RZLT | Rezolute | 0.20 | ||||
XOMAO | XOMA | 0.39 | ||||
ARMP | Armata Pharmaceuticals | 0.45 | ||||
SPRO | Spero Therapeutics | 0.86 | ||||
PCSA | Processa Pharmaceuticals | 1.50 | ||||
ELYM | Eliem Therapeutics | 1.90 | ||||
BOLT | Bolt Biotherapeutics | 2.37 | ||||
NRXP | NRX Pharmaceuticals | 2.48 | ||||
HCWB | HCW Biologics | 2.55 | ||||
IPHA | Innate Pharma | 5.00 | ||||
TPST | Tempest Therapeutics | 5.06 | ||||
PTIX | Protagenic Therapeutics | 5.42 | ||||
ANEB | Anebulo Pharmaceuticals | 12.10 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Biophytis Stock
If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |